行情

AXGN

AXGN

Axogen Inc.
NASDAQ

实时行情|Nasdaq Last Sale

15.59
-0.02
-0.13%
已收盘, 16:00 11/19 EST
开盘
15.71
昨收
15.61
最高
16.11
最低
15.56
成交量
30.01万
成交额
--
52周最高
35.11
52周最低
10.91
市值
6.15亿
市盈率(TTM)
-22.2746
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AXGN 新闻

  • 拼多多Q3净亏损超预期 盘前跌逾20%市值回落百度之后
  • 新浪财经.2小时前
  • 拼多多三季度营收低于市场预期 盘前大跌13%
  • 新浪科技.2小时前
  • 定价176港元,阿里巴巴首日盈利空间还有多大?
  • 华盛通.2小时前
  • 阿里巴巴融资880亿港元 为2010年以来香港最大IPO
  • 新浪财经.3小时前

更多

所属板块

先进医疗设备和技术
+1.39%
医疗设备和用品
+1.01%

热门股票

名称
价格
涨跌幅

AXGN 简况

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
展开

Webull提供Axogen Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。